Key statistics
As of last trade IRadimed Corp (46K:FRA) traded at 49.00, -8.41% below its 52-week high of 53.50, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 49.00 |
---|---|
High | 49.00 |
Low | 49.00 |
Bid | 50.50 |
Offer | 51.50 |
Previous close | 47.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.67m |
Free float | 7.99m |
P/E (TTM) | 36.46 |
Market cap | 674.61m USD |
EPS (TTM) | 1.46 USD |
Annual div (ADY) | 0.5692 EUR |
---|---|
Annual div yield (ADY) | 1.20% |
Div ex-date | Nov 15 2024 |
Div pay-date | Nov 25 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 07:07 GMT.
More ▼
Announcements
- IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
- IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
- IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
- IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
- IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
More ▼